Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

PD-1/PD-L1 Immune Checkpoint Therapy Demonstrates Favorable Safety Profile in Patients with Autoimmune and Cholestatic Liver Disease

Lorenz Kocheise,Ignazio Piseddu,Joscha Vonderlin,Eric T. Tjwa,Gustav Buescher,Lucy Meunier,Pia Goeggelmann,Francesca Fianchi,Jerome Dumortier,Mar Riveiro Barciela,Tom J. G. Gevers,Benedetta Terziroli Beretta-Piccoli,Maria-Carlota Londono,Sona Frankova,Thomas Roesner,Vincent Joerg,Constantin Schmidt,Fabian Glaser,Jan P. Sutter,Thorben W. Fruendt,Ansgar W. Lohse,Samuel Huber,Johann von Felden,Marcial Sebode,Kornelius Schulze

Frontiers in Immunology（2024）

Cited 0|Views2
Key words
autoimmune disease (AID),immune checkpoint inhibitors (ICI),autoimmune liver diseases (AILD),immune related adverse effects (irAEs),PD-1/PD-L1 immune checkpoint inhibitors,autoimmune hepatitis (AIH)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined